CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
High-Dose Chemotherapy of Cyclophosphamide, Thiotepa and Carboplatin (CTCb) followed by Autologous Stem-Cell Transplantation as a Consolidation for Breast Cancer Patients with 10 or more Positive Lymph Nodes: a 5-Year follow-Up Results
Hee-Jung Sohn, Sang-Hee Kim, Gyeong-Won Lee, Shin Kim, Jin-Hee Ahn, Sung-Bae Kim, Sang-We Kim, Woo Kun Kim, Cheolwon Suh
Cancer Research and Treatment. 2005;37(3):137-142.   Published online 2005 June 30    DOI: https://doi.org/10.4143/crt.2005.37.3.137

Excel Download

High-Dose Chemotherapy of Cyclophosphamide, Thiotepa and Carboplatin (CTCb) followed by Autologous Stem-Cell Transplantation as a Consolidation for Breast Cancer Patients with 10 or more Positive Lymph Nodes: a 5-Year follow-Up Results
Cancer Research and Treatment. 2005;37(3):137   Crossref logo
Link1 Link2

High-Dose Chemotherapy of Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) Followed by Autologous Stem-Cell Transplantation for Metastatic Breast Cancer Patients: A 6-Year Follow-Up Result
Cancer Research and Treatment. 2005;37(1):24   Crossref logo
Link1 Link2

ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancer
Medical Oncology. 2000;17(4):287-292   Crossref logo
Link1 Link2 Link3

Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up
Annals of Oncology. 2008;19(6):1082-1089   Crossref logo
Link1 Link2 Link3

Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up
Cancer Chemotherapy and Pharmacology. 1999;43(1):8-12   Crossref logo
Link1 Link2 Link3

CD34+ Cell Dose Requirements for Rapid Engraftment in a Sequential High-Dose Chemotherapy Regimen of Paclitaxel, Melphalan, and Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) with PBPC Support in Metastatic Breast Cancer
Journal of Hematotherapy & Stem Cell Research. 1999;8(4):357-363   Crossref logo
Link1

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes
Bone Marrow Transplantation. 1998;21(3):243-247   Crossref logo
Link1 Link2 Link3

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy
Biology of Blood and Marrow Transplantation. 2004;10(11):794-804   Crossref logo
Link1 Link2

Adjuvant chemotherapy with ac versus high dose mitoxantrone, cyclophosphamide (MC). filgrastrlm in operable breast cancer involving 10 or more axillary lymph nodes: 3 years follow-up result
European Journal of Cancer. 1997;33:S81   Crossref logo
Link1 Link2

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group
European Journal of Cancer. 2010;46(1):84-94   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.